Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2026-06-05 Report Publication Anno…
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
General Updates
Report Publication Announcement Classification · 91% confidence The document is not the Annual Report itself but an exchange filing (“Intimation under Regulation 30…”) informing shareholders and stock exchanges that the Annual Report for FY2025–26 has been published online and providing the web-link, together with the AGM notice. It does not contain actual financial statements; instead it announces the publication and availability of the report. This fits the “Report Publication Announcement” category.
2026-06-05 English
Pursuant to Regulation 36(1)(b) of SEBI(LODR) Regulations 2015 please find enclosed the letter sent to members providing weblink of Annual Report for F.Y. 2025-26
Report Publication Announcement Classification · 84% confidence The document is a short regulatory intimation under SEBI LODR Reg 30 notifying both stock exchanges and shareholders that the Annual Report for FY 2025-26 and the Notice of the 42nd AGM have been published online, with web-links provided. It does not contain any financial data itself but merely announces the availability of the report. This matches the Report Publication Announcement (RPA) category.
2026-06-05 English
Please find enclosed the Annual Report for the F.Y. 2025-26.
Annual Report Classification · 95% confidence The document is the full Annual Report for the Financial Year 2025-26 of ZIM Laboratories Limited. It contains the table of contents, corporate overview, management discussion & analysis, statutory reports, financial statements, and letters from the Chairman and CFO—i.e., a complete yearly report, not merely an announcement or summary. Thus, it matches the definition of an Annual Report (10-K). FY 2026
2026-06-05 English
The Notice of 42nd Annual General Meeting along with the Annual Report for the F.Y 2025-26 is enclosed.
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a detailed Notice of the 42nd Annual General Meeting sent under SEBI LODR Regulations to shareholders, including agenda, resolutions, e-voting instructions, related explanatory statements and annexures. It is a material provided to shareholders to inform them of the meeting and solicit their votes. This matches the definition of a Proxy Solicitation & Information Statement rather than an earnings release, financial report, or simple publication announcement.
2026-06-05 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 94% confidence The document is a formal Notice of the 42nd Annual General Meeting, sent to shareholders with agenda items, explanatory statements, e-voting instructions, and proxy information. It is not the full Annual Report itself, nor is it a post-meeting voting result. This matches the Proxy Solicitation & Information Statement category, which covers materials sent to shareholders to provide information and request votes for meetings.
2026-06-05 English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Major Shareholding Notification Classification · 89% confidence The document is a formal intimation to the stock exchanges under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations for an inter-se transfer of promoter shares, resulting in a change in the promoter’s shareholding percentage (from 24.90% to 25.05%). This matches the ‘Major Shareholding Notification’ category, which covers disclosures of changes in significant share ownership levels (crossing thresholds).
2026-06-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.